evidoria

← Back to browse

Good practice Imported

SINTEF TTO — Technology Transfer Office of Europe's Largest Independent Research Institute

Norway · Trondheim · See the Norway profile · See the Trondheim profile

Evidence: Descriptive / self-reported Top 54% 67/100 · Ask Evidence Copilot about this practice

SINTEF TTO, the venture arm of Norway's largest independent research institute, has invested NOK 500M in 42 spin-offs since 1987 and drawn NOK 3bn from outside investors, with managed venture capital growing from NOK 209M (2014) to NOK 517M (2022).

500 NOK million
SINTEF's own capital invested across spin-offs (cumulative) (1987–2025, cumulative as reported)
42
Spin-off companies backed (1987–2025, cumulative as reported)
3 NOK billion
External investment drawn in (cumulative) (1987–2025, cumulative as reported)
517 NOK million
Managed venture fund capital (2022)
SINTEF TTO — Technology Transfer Office of Europe's Largest Independent Research Institute

Details

Maturity
Established
Promoter
SINTEF (SINTEF TTO AS)
Period
1987–2025
Region (NUTS)
NO06
Keywords
technology transfer, venture capital, applied research commercialisation

Context

SINTEF TTO is the technology-transfer and venture-capital arm of SINTEF, one of Europe's largest independent applied-research institutes, based in Trondheim and sharing roughly 200 laboratories with the Norwegian University of Science and Technology (NTNU). It has operated since 1987.

Objectives

SINTEF TTO exists to commercialise research from SINTEF by deploying capital into spin-off companies and drawing in external co-investment.

Activities

SINTEF TTO invests SINTEF's own funds into spin-off companies and manages successive venture funds, drawing in external investors including the European Investment Fund.

Results

SINTEF TTO has invested NOK 500 million (about EUR 42 million) of SINTEF's own funds across 42 spin-off companies since 1987, while external investors — including the European Investment Fund — have contributed a further NOK 3 billion (about EUR 250 million). The office now manages three successive venture funds that have grown from NOK 209 million (2014) to NOK 500 million (2018) to NOK 517 million (2022), a documented eight-year scale-up in capital under management. Notable exits include SpinChip, a diagnostics spin-off acquired by a French group for EUR 138 million.

Conclusions

The most frequently cited aggregate revenue figure for SINTEF spin-offs (around NOK 4 billion a year) dates to 2015, and no public breakdown of gender or regional equity among founders was found, so this practice is best read as a strong capital-deployment and continuity track record rather than a fully transparent, current impact report.

Implementation
Indicative cost
High (€500k–€5M) — SINTEF TTO has deployed NOK 500 million (~EUR 42 million) of SINTEF's own funds since 1987; no separate figure for the office's own operating/administrative cost (as distinct from invested capital) was found.
Time to results
Long (> 3 years) — Operating continuously since 1987 (nearly 40 years), with three successive venture funds tracked from 2014 (NOK 209M) through 2018 (NOK 500M) to 2022 (NOK 517M).

Conditions for success

  • Co-location and shared laboratory infrastructure with the Norwegian University of Science and Technology (NTNU) — roughly 200 shared labs — gives spin-outs close access to applied research facilities.
  • Drawing in external co-investors, including the European Investment Fund, has grown capital under management from NOK 209M (2014) to NOK 517M (2022).

Common failure modes

  • No public breakdown of gender or regional equity among founders was found, limiting transparency on who benefits from the programme.
  • The most-cited aggregate spin-off revenue figure (~NOK 4bn/year) dates to 2015, so current-year impact reporting is not fully up to date.

Where it fits

Governance type
technology-transfer/venture arm of an independent applied-research institute (SINTEF)
Scale
national/institutional (Norway, ~2,000-employee institute)
Income level
high-income (Norway)

Commonly funded by

National / regional programmes

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful